BSE filing, BSE: 543499. Summary written from the filing by ALFA Finder's alert engine.
Achyut Healthcare Ltd: key numbers
- Share price
- ₹8.04
- Market cap
- ₹194.1 Cr
- Revenue (annual)
- ₹11.59 Cr
- Net profit (annual)
- ₹0.32 Cr
- P/E (TTM)
- 765.0×Sector 46.5×
- Promoter holding
- 47.40%+0.00% QoQ
- FII holding
- 5.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Achyut Healthcare Ltd
All →Achyut Healthcare Q2 FY27 Results: Net Profit ₹0 Cr
Achyut Healthcare Ltd reported revenue from operations of ₹1.7 Cr (-32.0% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Achyut Healthcare Board Meeting Date
Achyut Healthcare will hold a board meeting on 26 October 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results declaration.
Achyut Healthcare Management Change
Achyut Healthcare Ltd announced the re-appointment of Mr. Jigen J. Modi as Managing Director for a five-year term, following approval at the 31st Annual General Meeting.
Achyut Healthcare Annual General Meeting
Achyut Healthcare Limited conducted its 31st Annual General Meeting on September 29, 2026. Key resolutions included adopting audited financial statements and re-appointing directors and the Managing Director.
Achyut Healthcare Management Change
Achyut Healthcare re-appointed Jigen J. Modi as Executive Director and Sonu L. Jain and Rutvik S. Thakkar as Independent Directors for 60-month terms.
Achyut Healthcare Annual Report
Achyut Healthcare Limited has submitted its 31st Annual Report for the financial year 2025-2026. The Annual General Meeting is scheduled for 29th September, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.